Microtubule S-glutathionylation as a potential approach for antimitotic agents

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Chen, Wei ^a   Seefeldt, Teresa ^b   Young, Alan ^b   Zhang, Xiaoying ^c   Zhao, Yong ^d   Ruffolo, John ^b   Kaushik, Radhey S ^b   Guan, Xiangming ^b  

^a ZHEJIANG CANCER HOSPITAL   (China)

^b SOUTH DAKOTA STATE UNIVERSITY   (United States)

^c ACEA Bio Ltd   (China)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ACETYLAMINO 3 [4 (2 ACETYLAMINO 2 CARBOXYETHYLSULFANYLCARBONYLAMINO)PHENYL CARBAMOYLSULFANYL]PROPIONIC ACID; ANTIMITOTIC AGENT; GLUTATHIONE TRANSFERASE; PACLITAXEL; UNCLASSIFIED DRUG; VINBLASTINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLYMERIZATION; DRUG CYTOTOXICITY; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MALE; MICROTUBULE; MICROTUBULE ASSEMBLY; PROTEIN GLUTATHIONYLATION; PROTEIN MODIFICATION; WESTERN BLOTTING;

ANTIMITOTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLOW CYTOMETRY; GLUTATHIONE; HUMANS; MICROSCOPY, FLUORESCENCE; MICROTUBULES; PROPIONATES;

EID: 84862172783     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-245     Document Type: Article

References (36)

1. Sharp DJ, Rogers GC, Scholey JM. Microtubule motors in mitosis. Nature 2000, 407:41-47. 10.1038/35024000, 10993066.
2. Kanthou C, Tozer GM. The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells. Blood 2002, 99:2060-2069. 10.1182/blood.V99.6.2060, 11877280.
3. Dustin P. Microtubules, 2nd totally rev. edn 1984, Berlin; New York: Springer.
4. The role of multiple tubulin isoforms in cellular microtubule function 1994, New York: John Wiley & Sons, Raff EC.
5. Zhou J, Giannakakou P. Targeting microtubules for cancer chemotherapy. Curr Med Chem Anticancer Agents 2005, 5:65-71. 10.2174/1568011053352569, 15720262.
6. Nogales E, Wolf SG, Downing KH. Structure of the alpha beta tubulin dimer by electron crystallography. Nature 1998, 391:199-203. 10.1038/34465, 9428769.
7. Desai A, Mitchison TJ. Microtubule polymerization dynamics. Annu Rev Cell Dev Biol 1997, 13:83-117. 10.1146/annurev.cellbio.13.1.83, 9442869.
8. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004, 4:253-265. 10.1038/nrc1317, 15057285.
9. Landino LM, Moynihan KL, Todd JV, Kennett KL. Modulation of the redox state of tubulin by the glutathione/glutaredoxin reductase system. Biochem Biophys Res Commun 2004, 314:555-560. 10.1016/j.bbrc.2003.12.126, 14733943.
10. Cowan NJ. Tubulin genes and the diversity of microtubule function. Oxf Surv Eukaryot Genes 1984, 1:36-60.
11. Britto PJ, Knipling L, Wolff J. The local electrostatic environment determines cysteine reactivity of tubulin. J Biol Chem 2002, 277:29018-29027. 10.1074/jbc.M204263200, 12023292.
12. Britto PJ, Knipling L, McPhie P, Wolff J. Thiol-disulphide interchange in tubulin: kinetics and the effect on polymerization. Biochem J 2005, 389:549-558. 10.1042/BJ20042118, 1175133, 15743274.
13. Landino LM, Brown CM, Edson CA, Gilbert LJ, Grega-Larson N, Wirth AJ, Lane KC. Fluorescein-labeled glutathione to study protein S-glutathionylation. Anal Biochem 2010, 402:102-104. 10.1016/j.ab.2010.02.006, 2883778, 20156418.
14. Huber K, Patel P, Zhang L, Evans H, Westwell AD, Fischer PM, Chan S, Martin S. 2-[(1-methylpropyl)dithio]-1H-imidazole inhibits tubulin polymerization through cysteine oxidation. Mol Cancer Ther 2008, 7:143-151. 10.1158/1535-7163.MCT-07-0486, 18202017.
15. Ducki S. Antimitotic chalcones and related compounds as inhibitors of tubulin assembly. Anticancer Agents Med Chem 2009, 9:336-347. 10.2174/1871520610909030336, 19275525.
16. Chen W, Zhao Y, Seefeldt T, Guan X. Determination of thiols and disulfides via HPLC quantification of 5-thio-2-nitrobenzoic acid. J Pharm Biomed Anal 2008, 48:1375-1380. 10.1016/j.jpba.2008.08.033, 2684446, 18926658.
17. Zhao Y, Seefeldt T, Chen W, Wang X, Matthees D, Hu Y, Guan X. Effects of glutathione reductase inhibition on cellular thiol redox state and related systems. Arch Biochem Biophys 2009, 485:56-62. 10.1016/j.abb.2009.03.001, 2709784, 19272349.
18. Klatt P, Lamas S. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem 2000, 267:4928-4944. 10.1046/j.1432-1327.2000.01601.x, 10931175.
19. Townsend DM. S-glutathionylation: indicator of cell stress and regulator of the unfolded protein response. Mol Interv 2007, 7:313-324. 10.1124/mi.7.6.7, 18199853.
20. Seefeldt T, Zhao Y, Chen W, Raza AS, Carlson L, Herman J, Stoebner A, Hanson S, Foll R, Guan X. Characterization of a novel dithiocarbamate glutathione reductase inhibitor and its use as a tool to modulate intracellular glutathione. J Biol Chem 2009, 284:2729-2737. 2631970, 19049979.
21. Bonifacino JS, Dell'Angelica EC, Springer TA. Immunoprecipitation. Curr Protoc Neurosci 2006, Chapter 5:Unit 5. 24. 5.24.1-5.24.28.
22. Cheng G, Ikeda Y, Iuchi Y, Fujii J. Detection of S-glutathionylated proteins by glutathione S-transferase overlay. Arch Biochem Biophys 2005, 435:42-49. 10.1016/j.abb.2004.12.016, 15680905.
23. Kaur G, Hollingshead M, Holbeck S, Schauer-Vukasinovic V, Camalier RF, Domling A, Agarwal S. Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product. Biochem J 2006, 396:235-242. 10.1042/BJ20051735, 1462728, 16489930.
24. Kiselyov A, Balakin KV, Tkachenko SE, Savchuk N, Ivachtchenko AV. Recent progress in discovery and development of antimitotic agents. Anticancer Agents Med Chem 2007, 7:189-208. 10.2174/187152007780058650, 17348827.
25. Schmidt M, Bastians H. Mitotic drug targets and the development of novel anti-mitotic anticancer drugs. Drug Resist Update 2007, 10:162-181.
26. Nagle A, Hur W, Gray NS. Antimitotic agents of natural origin. Curr Drug Targets 2006, 7:305-326. 10.2174/138945006776054933, 16515529.
27. Dalle-Donne I, Milzani A, Gagliano N, Colombo R, Giustarini D, Rossi R. Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid Redox Signal 2008, 10:445-473. 10.1089/ars.2007.1716, 18092936.
28. Dalle-Donne I, Rossi R, Colombo G, Giustarini D, Milzani A. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem Sci 2009, 34:85-96. 10.1016/j.tibs.2008.11.002, 19135374.
29. Dalle-Donne I, Rossi R, Giustarini D, Colombo R, Milzani A. S-glutathionylation in protein redox regulation. Free Radic Biol Med 2007, 43:883-898. 10.1016/j.freeradbiomed.2007.06.014, 17697933.
30. Gallogly MM, Mieyal JJ. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr Opin Pharmacol 2007, 7:381-391. 10.1016/j.coph.2007.06.003, 17662654.
31. Spadaro D, Yun BW, Spoel SH, Chu C, Wang YQ, Loake GJ. The redox switch: dynamic regulation of protein function by cysteine modifications. Physiol Plant 2010, 138:360-371. 10.1111/j.1399-3054.2009.01307.x, 19912563.
32. Beer SM, Taylor ER, Brown SE, Dahm CC, Costa NJ, Runswick MJ, Murphy MP. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant DEFENSE. J Biol Chem 2004, 279:47939-47951. 10.1074/jbc.M408011200, 15347644.
33. Holmgren A, Johansson C, Berndt C, Lonn ME, Hudemann C, Lillig CH. Thiol redox control via thioredoxin and glutaredoxin systems. Biochem Soc Trans 2005, 33:1375-1377. 10.1042/BST20051375, 16246122.
34. Reynaert NL, van der Vliet A, Guala AS, McGovern T, Hristova M, Pantano C, Heintz NH, Heim J, Ho YS, Matthews DE, et al. Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci U S A 2006, 103:13086-13091. 10.1073/pnas.0603290103, 1559757, 16916935.
35. Zhao Y, Seefeldt T, Chen W, Carlson L, Stoebner A, Hanson S, Foll R, Matthees DP, Palakurthi S, Guan X. Increase in thiol oxidative stress via glutathione reductase inhibition as a novel approach to enhance cancer sensitivity to X-ray irradiation. Free Radic Biol Med 2009, 47:176-183. 10.1016/j.freeradbiomed.2009.04.022, 2745482, 19397999.
36. Carletti B, Passarelli C, Sparaco M, Tozzi G, Pastore A, Bertini E, Piemonte F. Effect of protein glutathionylation on neuronal cytoskeleton: a potential link to neurodegeneration. Neuroscience 2011, 192:285-294.